Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Cash & Equivalents (2016 - 2025)

Healthy Extracts' Cash & Equivalents history spans 11 years, with the latest figure at $146935.0 for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 31.17% year-over-year to $146935.0; the TTM value through Dec 2025 reached $146935.0, up 31.17%, while the annual FY2025 figure was $146935.0, 31.17% up from the prior year.
  • Cash & Equivalents reached $146935.0 in Q4 2025 per HYEX's latest filing, down from $189452.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $286939.0 in Q2 2021 to a low of $19441.0 in Q4 2023.
  • Average Cash & Equivalents over 5 years is $136175.8, with a median of $116968.0 recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: plummeted 70.44% in 2022, then soared 476.2% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $222098.0 in 2021, then tumbled by 70.44% to $65651.0 in 2022, then plummeted by 70.39% to $19441.0 in 2023, then skyrocketed by 476.2% to $112020.0 in 2024, then soared by 31.17% to $146935.0 in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Cash & Equivalents are $146935.0 (Q4 2025), $189452.0 (Q3 2025), and $200495.0 (Q2 2025).